Viprinex is an injectable drug derived from the venom of a Malayan pit viper. Viprinex acts as a defibrinogenating agent, and is being studied to treat inschemic stroke. While it is not yet approved by the Food and Drug Administration in the United States, the FDA has accelerated research on Viprinex as of January 2005. Researchers are aiming for Viprinex to be an option to stroke sufferers in the near future.
Fast Facts:
- Brand: Viprinex
- Generic: Ancrod
- Route: Injection
- Investigated for inschemic stroke
- Derived from venom of Malayan pit viper
Disclaimer: The content on this page is not a substitute for professional medical advice. Please contact your doctor for more information on Viprinex.
Viprinex Clinical Studies and Research
Internet Stroke Center: Stroke Trials Registry
ClinicalTrials.gov: Ancrod (Viprinex) Clinical Trials
- This result, Viprinex, is currently a stub, a brief collection of the best links for this story. The page will be updated as we find more information.
Help Mahalo complete this search! Let us know if you've found additional quality links about Viprinex on Google, Del.icio.us, Digg or elsewhere, and we can expand this result.
